China National Accord Medicines Corp Ltd (000028) — Cash Flow Quality Index
China National Accord Medicines Corp Ltd (000028) has a Cash Flow Quality Index of -1.46x as of September 2025. Operating cash flow of CN¥-425.23 Million is below net income of CN¥291.21 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore China National Accord Medicines Corp Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China National Accord Medicines Corp Ltd Cash Flow Quality Index (1998–2024)
Historical Cash Flow Quality Index for China National Accord Medicines Corp Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does China National Accord Medicines Corp Ltd generate cash.
Annual Cash Flow Quality Index for China National Accord Medicines Corp Ltd (1998–2024)
Year-by-year earnings quality comparison for China National Accord Medicines Corp Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 13.80x | CN¥3.27 Billion | CN¥237.00 Million | ▲ +651.6% |
| 2023 | 1.84x | CN¥2.94 Billion | CN¥1.60 Billion | ▲ +27.1% |
| 2022 | 1.45x | CN¥2.56 Billion | CN¥1.77 Billion | ▲ +33.4% |
| 2021 | 1.08x | CN¥1.66 Billion | CN¥1.53 Billion | ▲ +24.1% |
| 2020 | 0.87x | CN¥1.50 Billion | CN¥1.72 Billion | ▼ -35.2% |
| 2019 | 1.35x | CN¥2.00 Billion | CN¥1.48 Billion | ▲ +37.4% |
| 2018 | 0.98x | CN¥1.32 Billion | CN¥1.35 Billion | ▼ -11.7% |
| 2017 | 1.11x | CN¥1.29 Billion | CN¥1.16 Billion | ▼ -3.3% |
| 2016 | 1.15x | CN¥1.47 Billion | CN¥1.28 Billion | ▼ -13.7% |
| 2015 | 1.33x | CN¥1.05 Billion | CN¥787.35 Million | ▲ +211.9% |
| 2014 | -1.19x | CN¥-796.70 Million | CN¥669.84 Million | ▼ -236.6% |
| 2013 | 0.87x | CN¥465.03 Million | CN¥534.22 Million | ▲ +30.0% |
| 2012 | 0.67x | CN¥323.96 Million | CN¥483.68 Million | ▼ -3.4% |
| 2011 | 0.69x | CN¥227.32 Million | CN¥327.82 Million | ▼ -57.2% |
| 2010 | 1.62x | CN¥428.16 Million | CN¥264.22 Million | ▲ +18.6% |
| 2009 | 1.37x | CN¥270.85 Million | CN¥198.26 Million | ▼ -10.0% |
| 2008 | 1.52x | CN¥246.58 Million | CN¥162.45 Million | ▲ +116.2% |
| 2007 | 0.70x | CN¥87.70 Million | CN¥124.91 Million | ▼ -70.0% |
| 2006 | 2.34x | CN¥181.73 Million | CN¥77.76 Million | ▼ -43.6% |
| 2005 | 4.15x | CN¥148.28 Million | CN¥35.77 Million | ▼ -15.4% |
| 2004 | 4.90x | CN¥130.30 Million | CN¥26.58 Million | ▼ -8.9% |
| 2003 | 5.38x | CN¥81.22 Million | CN¥15.11 Million | ▼ -20.1% |
| 2002 | 6.73x | CN¥28.76 Million | CN¥4.28 Million | ▲ +227.3% |
| 2001 | 2.06x | CN¥71.16 Million | CN¥34.61 Million | ▲ +130.7% |
| 1999 | 0.89x | CN¥22.84 Million | CN¥25.62 Million | ▲ +141.6% |
| 1998 | 0.37x | CN¥5.21 Million | CN¥14.12 Million | — |